Top

Journal of Assisted Reproduction and Genetics

Published in:

01-02-2019 | Reproductive Physiology and Disease

MiRNA-99a can regulate proliferation and apoptosis of human granulosa cells via targeting IGF-1R in polycystic ovary syndrome

Authors: Yudi Geng, Cong Sui, Yang Xun, Qiaohong Lai, Lei Jin

Published in: Journal of Assisted Reproduction and Genetics | Issue 2/2019

Abstract

Purpose

We aimed to evaluate the regulation of miR-99a to the biological functions of granulosa cells in polycystic ovary syndrome (PCOS) via targeting IGF-1R.

Methods

We collected aspirated follicular fluid in both patients with and without PCOS. Granulosa cells (GCs) were isolated through Percoll differential centrifugation to detect both miR-99a and IGF-1R expressions. We further transfected COV434 cells with miR-99a mimics to establish a miRNA-99a (miR-99a) overexpression model. We explored the regulation of miR-99a to the proliferation and apoptosis of human GCs via IGF-1R in COV434. The effect of different insulin concentrations on miR-99a expression was also evaluated.

Results

MiR-99a was significantly downregulated while IGF-1R was upregulated in patients with PCOS. MiR-99a can regulate IGF-1R on a post-transcriptional level. After transfection of miR-99a mimics, the proliferation rate was decreased and apoptosis rate was increased significantly in COV434. Exogenous insulin-like growth factor 1 (IGF-1) treatment could reverse the effect of miR-99a. MiR-99a was negatively and dose-dependently regulated by insulin in vitro.

Conclusions

MiR-99a expression was downregulated in patients with PCOS, the degree of which may be closely related to insulin resistance and hyperinsulinemia. MiR-99a could attenuate proliferation and promote apoptosis of human GCs through targeting IGF-1R, which could partly explain the abnormal folliculogenesis in PCOS.

Dalmay T. MicroRNAs and cancer. J Intern Med. 2008;263(4):366–75. https://doi.org/10.1111/j.1365-2796.2008.01926.x.CrossRefPubMed

Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136(2):215–33. https://doi.org/10.1016/j.cell.2009.01.002.CrossRefPubMedPubMedCentral

McKenna LB, Schug J, Vourekas A, McKenna JB, Bramswig NC, Friedman JR, et al. MicroRNAs control intestinal epithelial differentiation, architecture, and barrier function. Gastroenterology. 2010;139(5):1654–64, 64 e1. https://doi.org/10.1053/j.gastro.2010.07.040.CrossRefPubMedPubMedCentral

Fan C, Lin Y, Mao Y, Huang Z, Liu AY, Ma H, et al. MicroRNA-543 suppresses colorectal cancer growth and metastasis by targeting KRAS, MTA1 and HMGA2. Oncotarget. 2016;7(16):21825–39. https://doi.org/10.18632/oncotarget.7989.CrossRefPubMedPubMedCentral

Ge X, Liu X, Lin F, Li P, Liu K, Geng R, et al. MicroRNA-421 regulated by HIF-1alpha promotes metastasis, inhibits apoptosis, and induces cisplatin resistance by targeting E-cadherin and caspase-3 in gastric cancer. Oncotarget. 2016;7(17):24466–82. https://doi.org/10.18632/oncotarget.8228.CrossRefPubMedPubMedCentral

Shukla GC, Singh J, Barik S. MicroRNAs: processing, maturation, target recognition and regulatory functions. Mol Cell Pharmacol. 2011;3(3):83–92.PubMedPubMedCentral

Mei LL, Qiu YT, Huang MB, Wang WJ, Bai J, Shi ZZ. MiR-99a suppresses proliferation, migration and invasion of esophageal squamous cell carcinoma cells through inhibiting the IGF1R signaling pathway. Cancer Biomark. 2017;20:527–37. https://doi.org/10.3233/CBM-170345.CrossRefPubMed

Wang X, Li Y, Qi W, Zhang N, Sun M, Huo Q, et al. MicroRNA-99a inhibits tumor aggressive phenotypes through regulating HOXA1 in breast cancer cells. Oncotarget. 2015;6(32):32737–47. https://doi.org/10.18632/oncotarget.5355.PubMedPubMedCentralCrossRef

Xing B, Ren C. Tumor-suppressive miR-99a inhibits cell proliferation via targeting of TNFAIP8 in osteosarcoma cells. Am J Transl Res. 2016;8(2):1082–90.PubMedPubMedCentral

10.

Maugeri M, Barbagallo D, Barbagallo C, Banelli B, Di Mauro S, Purrello F, et al. Altered expression of miRNAs and methylation of their promoters are correlated in neuroblastoma. Oncotarget. 2016;7(50):83330–41. https://doi.org/10.18632/oncotarget.13090.CrossRefPubMedPubMedCentral

11.

Weroha SJ, Haluska P. The insulin-like growth factor system in cancer. Endocrinol Metab Clin N Am. 2012;41(2):335–50, vi. https://doi.org/10.1016/j.ecl.2012.04.014.CrossRef

12.

Goodarzi MO, Dumesic DA, Chazenbalk G, Azziz R. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol. 2011;7(4):219–31. https://doi.org/10.1038/nrendo.2010.217.CrossRefPubMed

13.

Moran L, Teede H. Metabolic features of the reproductive phenotypes of polycystic ovary syndrome. Hum Reprod Update. 2009;15(4):477–88. https://doi.org/10.1093/humupd/dmp008.CrossRefPubMed

14.

Eek D, Paty J, Black P, Celeste Elash CA, Reaney M. A comprehensive disease model of polycystic ovary syndrome (Pcos). Value Health. 2015;18(7):A722. https://doi.org/10.1016/j.jval.2015.09.2739.CrossRefPubMed

15.

Diamanti-Kandarakis E, Piperi C, Spina J, Argyrakopoulou G, Papanastasiou L, Bergiele A, et al. Polycystic ovary syndrome: the influence of environmental and genetic factors. Hormones. 2006;5(1):17–34.CrossRefPubMed

16.

Artimani T, Saidijam M, Aflatoonian R, Amiri I, Ashrafi M, Shabab N, et al. Estrogen and progesterone receptor subtype expression in granulosa cells from women with polycystic ovary syndrome. Gynecol Endocrinol. 2015;31(5):379–83. https://doi.org/10.3109/09513590.2014.1001733.CrossRefPubMed

17.

Stubbs SA, Stark J, Dilworth SM, Franks S, Hardy K. Abnormal preantral folliculogenesis in polycystic ovaries is associated with increased granulosa cell division. J Clin Endocrinol Metab. 2007;92(11):4418–26. https://doi.org/10.1210/jc.2007-0729.CrossRefPubMed

18.

Das M, Djahanbakhch O, Hacihanefioglu B, Saridogan E, Ikram M, Ghali L, et al. Granulosa cell survival and proliferation are altered in polycystic ovary syndrome. J Clin Endocrinol Metab. 2008;93(3):881–7. https://doi.org/10.1210/jc.2007-1650.CrossRefPubMed

19.

Chang RJ, Cook-Andersen H. Disordered follicle development. Mol Cell Endocrinol. 2013;373(1–2):51–60. https://doi.org/10.1016/j.mce.2012.07.011.CrossRefPubMed

20.

Yu YS, Sui HS, Han ZB, Li W, Luo MJ, Tan JH. Apoptosis in granulosa cells during follicular atresia: relationship with steroids and insulin-like growth factors. Cell Res. 2004;14(4):341–6. https://doi.org/10.1038/sj.cr.7290234.CrossRefPubMed

21.

Cakir E, Topaloglu O, Colak Bozkurt N, Karbek Bayraktar B, Gungunes A, Sayki Arslan M, et al. Insulin-like growth factor 1, liver enzymes, and insulin resistance in patients with PCOS and hirsutism. Turkish J Med Sci. 2014;44(5):781–6.CrossRef

22.

Hossain MM, Cao M, Wang Q, Kim JY, Schellander K, Tesfaye D, et al. Altered expression of miRNAs in a dihydrotestosterone-induced rat PCOS model. J Ovarian Res. 2013;6(1):36. https://doi.org/10.1186/1757-2215-6-36.CrossRefPubMedPubMedCentral

23.

Roth LW, McCallie B, Alvero R, Schoolcraft WB, Minjarez D, Katz-Jaffe MG. Altered microRNA and gene expression in the follicular fluid of women with polycystic ovary syndrome. J Assist Reprod Genet. 2014;31(3):355–62. https://doi.org/10.1007/s10815-013-0161-4.CrossRefPubMedPubMedCentral

24.

Liu S, Zhang X, Shi C, Lin J, Chen G, Wu B, et al. Altered microRNAs expression profiling in cumulus cells from patients with polycystic ovary syndrome. J Transl Med. 2015;13:238. https://doi.org/10.1186/s12967-015-0605-y.CrossRefPubMedPubMedCentral

25.

Zhang ZW, Guo RW, Lv JL, Wang XM, Ye JS, Lu NH, et al. MicroRNA-99a inhibits insulin-induced proliferation, migration, dedifferentiation, and rapamycin resistance of vascular smooth muscle cells by inhibiting insulin-like growth factor-1 receptor and mammalian target of rapamycin. Biochem Biophys Res Commun. 2017;486(2):414–22. https://doi.org/10.1016/j.bbrc.2017.03.056.CrossRefPubMed

26.

Tao J, Yang X, Han Z, Lu P, Wang J, Liu X, et al. Serum MicroRNA-99a helps detect acute rejection in renal transplantation. Transplant Proc. 2015;47(6):1683–7. https://doi.org/10.1016/j.transproceed.2015.04.094.CrossRefPubMed

27.

Yang SY, Wang YQ, Gao HM, Wang B, He Q. The clinical value of circulating miR-99a in plasma of patients with acute myocardial infarction. Eur Rev Med Pharmacol Sci. 2016;20(24):5193–7.PubMed

28.

Jin Y, Tymen SD, Chen D, Fang ZJ, Zhao Y, Dragas D, et al. MicroRNA-99 family targets AKT/mTOR signaling pathway in dermal wound healing. PLoS One. 2013;8(5):e64434. https://doi.org/10.1371/journal.pone.0064434.CrossRefPubMedPubMedCentral

29.

Yao G, Yin M, Lian J, Tian H, Liu L, Li X, et al. MicroRNA-224 is involved in transforming growth factor-beta-mediated mouse granulosa cell proliferation and granulosa cell function by targeting Smad4. Mol Endocrinol. 2010;24(3):540–51. https://doi.org/10.1210/me.2009-0432.CrossRefPubMedPubMedCentral

30.

Lei L, Jin S, Gonzalez G, Behringer RR, Woodruff TK. The regulatory role of Dicer in folliculogenesis in mice. Mol Cell Endocrinol. 2010;315(1–2):63–73. https://doi.org/10.1016/j.mce.2009.09.021.CrossRefPubMed

31.

Hong X, Luense LJ, McGinnis LK, Nothnick WB, Christenson LK. Dicer1 is essential for female fertility and normal development of the female reproductive system. Endocrinology. 2008;149(12):6207–12. https://doi.org/10.1210/en.2008-0294.CrossRefPubMedPubMedCentral

32.

Ding CF, Chen WQ, Zhu YT, Bo YL, Hu HM, Zheng RH. Circulating microRNAs in patients with polycystic ovary syndrome. Hum Fertil. 2015;18(1):22–9. https://doi.org/10.3109/14647273.2014.956811.CrossRef

33.

Kota J, Chivukula RR, O'Donnell KA, Wentzel EA, Montgomery CL, Hwang HW, et al. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell. 2009;137(6):1005–17. https://doi.org/10.1016/j.cell.2009.04.021.CrossRefPubMedPubMedCentral

34.

Teixeira Filho FL, Baracat EC, Lee TH, Suh CS, Matsui M, Chang RJ, et al. Aberrant expression of growth differentiation factor-9 in oocytes of women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2002;87(3):1337–44. https://doi.org/10.1210/jcem.87.3.8316.CrossRefPubMed

35.

Li D, Liu X, Lin L, Hou J, Li N, Wang C, et al. MicroRNA-99a inhibits hepatocellular carcinoma growth and correlates with prognosis of patients with hepatocellular carcinoma. J Biol Chem. 2011;286(42):36677–85. https://doi.org/10.1074/jbc.M111.270561.CrossRefPubMedPubMedCentral

36.

Brahmkhatri VP, Prasanna C, Atreya HS. Insulin-like growth factor system in cancer: novel targeted therapies. Biomed Res Int. 2015;2015:538019–24. https://doi.org/10.1155/2015/538019.CrossRefPubMedPubMedCentral

37.

Stubbs SA, Webber LJ, Stark J, Rice S, Margara R, Lavery S, et al. Role of insulin-like growth factors in initiation of follicle growth in normal and polycystic human ovaries. J Clin Endocrinol Metab. 2013;98(8):3298–305. https://doi.org/10.1210/jc.2013-1378.CrossRefPubMed

38.

Louhio H, Hovatta O, Sjoberg J, Tuuri T. The effects of insulin, and insulin-like growth factors I and II on human ovarian follicles in long-term culture. Mol Hum Reprod. 2000;6(8):694–8.CrossRefPubMed

39.

Premoli AC, Santana LF, Ferriani RA, Moura MD, De Sa MF, Reis RM. Growth hormone secretion and insulin-like growth factor-1 are related to hyperandrogenism in nonobese patients with polycystic ovary syndrome. Fertil Steril. 2005;83(6):1852–5. https://doi.org/10.1016/j.fertnstert.2004.10.057.CrossRefPubMed

40.

Velazquez MA, Hermann D, Kues WA, Niemann H. Increased apoptosis in bovine blastocysts exposed to high levels of IGF1 is not associated with downregulation of the IGF1 receptor. Reproduction. 2011;141(1):91–103. https://doi.org/10.1530/REP-10-0336.CrossRefPubMed

41.

Luo L, Wang Q, Chen M, Yuan G, Wang Z, Zhou C. IGF-1 and IGFBP-1 in peripheral blood and decidua of early miscarriages with euploid embryos: comparison between women with and without PCOS. Gynecol Endocrinol. 2016;32(7):538–42. https://doi.org/10.3109/09513590.2016.1138459.CrossRefPubMed

42.

Homburg R, Pariente C, Lunenfeld B, Jacobs HS. The role of insulin-like growth factor-1 (IGF-1) and IGF binding protein-1 (IGFBP-1) in the pathogenesis of polycystic ovary syndrome. Hum Reprod. 1992;7(10):1379–83.CrossRefPubMed

43.

Thierry van Dessel HJ, Lee PD, Faessen G, Fauser BC, Giudice LC. Elevated serum levels of free insulin-like growth factor I in polycystic ovary syndrome. J Clin Endocrinol Metab. 1999;84(9):3030–5. https://doi.org/10.1210/jcem.84.9.5941.PubMedCrossRef

44.

Li W, Wang J, Chen QD, Qian X, Li Q, Yin Y, et al. Insulin promotes glucose consumption via regulation of miR-99a/mTOR/PKM2 pathway. PLoS One. 2013;8(6):e64924. https://doi.org/10.1371/journal.pone.0064924.CrossRefPubMedPubMedCentral

45.

Cai G, Ma X, Chen B, Huang Y, Liu S, Yang H, et al. MicroRNA-145 negatively regulates cell proliferation through targeting IRS1 in isolated ovarian granulosa cells from patients with polycystic ovary syndrome. Reprod Sci. 2016;24(6):902–10. https://doi.org/10.1177/1933719116673197.CrossRefPubMed

Title: MiRNA-99a can regulate proliferation and apoptosis of human granulosa cells via targeting IGF-1R in polycystic ovary syndrome
Authors: Yudi Geng
Cong Sui
Yang Xun
Qiaohong Lai
Lei Jin
Publication date: 01-02-2019
Publisher: Springer US
Published in: Journal of Assisted Reproduction and Genetics / Issue 2/2019
Print ISSN: 1058-0468
Electronic ISSN: 1573-7330
DOI: https://doi.org/10.1007/s10815-018-1335-x

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

MiRNA-99a can regulate proliferation and apoptosis of human granulosa cells via targeting IGF-1R in polycystic ovary syndrome

Abstract

Purpose

Methods

Results

Conclusions

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 2/2019

Reactive oxygen species-induced alterations in H19-Igf2 methylation patterns, seminal plasma metabolites, and semen quality

Business models and provider satisfaction in in vitro fertilization centers in the USA

Effect of endometrial mechanical stimulation in an unselected population undergoing in vitro fertilization: futility analysis of a double-blind randomized controlled trial

Treatment of female rhesus macaques with a somatostatin receptor antagonist that increases oocyte fertilization rates without affecting post-fertilization development outcomes

Chromosome constitution of equal-sized three-cell embryos using next-generation sequencing technology

Deliveries following fertility preservation by ovarian tissue cryopreservation without autotransplantation—what should be expected?